Hyperhidrosis
Conditions
Brief summary
A study using Botulinum Toxin Type A in adolescents with axillary hyperhidrosis.
Interventions
BIOLOGICALBotulinum Toxin Type A
100 U up to 6 times during the study depending on the response to treatment
Sponsors
Allergan
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
12 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
* Marked axillary hyperhidrosis
Exclusion criteria
* Previous use of botulinum toxin for hyperhidrosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subject's assessment of the severity of hyperhidrosis using the HDS Scale | Monthly |
Secondary
| Measure | Time frame |
|---|---|
| Measurement of axillary sweat production | Week 4, Week 8 and any re-injection visit |
Countries
Canada, United States
Outcome results
None listed